Brand semaglutide
Sold by Walgreens Weight Management · every brand semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$248
| Medication · Injectable, first two months (thru 12/31/2026 offer) | $199 |
|---|---|
| Required membership | $49 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Injectable, first two months (thru 12/31/2026 offer) “Through December 31, 2026, get the first two months of Wegovy injectables for as low as $199/month through a Novo Nordisk introductory offer, subsequent doses up to $349/month, restrictions and exclusions apply † .” | Per month$199 | Charged today$199 |
We earn nothing from this link. Walgreens Weight Management has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Live visit |
|---|---|
| Membership | Required. $49 per month. “Initial video visits with a provider start at $49, follow-up chat visits and additional video visits (if needed) are $49 each. Note: The cost of the medication is separate from cost of the clinician visit.” |
Not yet checked: pharmacy, states, cancellation and consult fee.
Recorded from walgreens.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The $49 fee is charged per clinician visit rather than as a flat recurring monthly membership, but it is a mandatory access fee that every medication price on the site explicitly excludes ('This service ... no subscriptions required' / 'the cost of medication is separate from the cost of the clinician visit'), so it is recorded here as membership rather than as part of any price. 'Available in most states*' is never footnoted with an actual state list anywhere in the pages fetched. Walgreens also sells orforglipron (Foundayo™) and liraglutide (Saxenda®), which fall outside this register's fixed drug list and were not recorded. No subscription/cancellation language was found — the model here is pay-per-visit, not a cancelable recurring plan.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.